KPIs & Operating Metrics(New)
Biopharma Testing VolumeBreakdown Of AssetsClinical VolumeContractual ObligationsCost Of RevenueCost Of Revenue By SegmentDeferred RevenueEmployee StatisticsGross Margin %Gross Margin By Segment %Gross ProfitGross Profit By SegmentIncome Before Provision For Income TaxesNon Gaap ProfitabilityNon Gaap Profitability %Non Gaap Profitability AnnualNon Gaap Profitability Annual %Opex As A % Of RevenueOPEX BreakdownProperty And Equipment, NetRevenueRevenue By RegionRevenue By Region %Revenue By Region AnnualRevenue By Region Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Guardant Health (GH) Gross Profit (2017 - 2025)

Historic Gross Profit for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to $137.8 million.

  • Guardant Health's Gross Profit rose 4725.1% to $137.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $446.5 million, marking a year-over-year increase of 2651.03%. This contributed to the annual value of $374.1 million for FY2024, which is 3920.8% up from last year.
  • According to the latest figures from Q3 2025, Guardant Health's Gross Profit is $137.8 million, which was up 4725.1% from $112.5 million recorded in Q2 2025.
  • Guardant Health's Gross Profit's 5-year high stood at $137.8 million during Q3 2025, with a 5-year trough of $31.7 million in Q1 2022.
  • For the 5-year period, Guardant Health's Gross Profit averaged around $69.7 million, with its median value being $66.1 million (2023).
  • Its Gross Profit has fluctuated over the past 5 years, first crashed by 2856.05% in 2022, then soared by 10007.56% in 2023.
  • Over the past 5 years, Guardant Health's Gross Profit (Quarter) stood at $48.5 million in 2021, then fell by 6.27% to $45.5 million in 2022, then soared by 66.99% to $75.9 million in 2023, then increased by 27.82% to $97.1 million in 2024, then soared by 42.01% to $137.8 million in 2025.
  • Its Gross Profit stands at $137.8 million for Q3 2025, versus $112.5 million for Q2 2025 and $99.2 million for Q1 2025.